• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Survey: Sponsors 62% more likely to engage CROs than 5 years ago

Survey: Sponsors 62% more likely to engage CROs than 5 years ago

July 21, 2016
CenterWatch Staff

A recent survey by Worldwide Clinical Trials reveals that 62% of respondents are more likely to engage a CRO partner for clinical research than they were five years ago, demonstrating the increasingly vital role that CROs are playing in modern drug development, and the importance of partnering with a CRO that offers medical and scientific expertise.

Conducted at DIA 2016, held June 26-30, 2016, in Philadelphia, Pa., the survey gauged the opinions of nearly 300 drug development leaders and executives from pharmaceutical and biotechnology companies who visited the Worldwide booth during the DIA meeting.

“As one of the industry’s leading events, we saw DIA as an opportunity to gather input from leaders in the industry—to discover what is important to sponsors, including potential barriers to drug development, areas where they are looking for CRO innovation, and key factors they consider when selecting a CRO partner,” said Peter Benton, president and COO at Worldwide Clinical Trials.

In response to a question about the impact of innovative approaches from a CRO, almost a third (29%) of respondents said that innovation in overall trial management would have the greatest impact on clinical development, with just over a quarter (26%) saying that innovation in patient recruitment and retention would have the second biggest impact.

When considering barriers to a new drug development, those surveyed by Worldwide selected the cost of discovery research and clinical development, regulatory guidance and the risk associated with the clinical development process as the most critical issues. In terms of choosing the perfect CRO partner, respondents listed the capability for the CRO to deliver high quality data as the most important factor (83%), closely followed by the ability for the CRO to deliver on time (76%) and within budget (68%). Interestingly, the findings demonstrate little variation in when respondents are likely engage with a CRO partner, with later phase investigations (phase II to phase III) narrowly ranking the highest, over earlier phase investigations.

“The survey results confirm our focus at Worldwide, where we deliver a strategic balance of science, medicine and operations, including effective planning and risk management, open and ongoing communication, and frequent measurement and reporting. This ensures that we can achieve successful trial execution for our research partners,” said Benton.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing